NTRK fusion positive cancer

Neoplasm associated with the expression of a Neurotrophic Tyrosine Receptor Kinase (NTRK) Fusion. NTRK fusion-positive tumors have been identified in a broad range of solid tumor types, including breast, cholangiocarcinoma, colorectal, gynecological, neuroendocrine, non-small cell lung, salivary gland, pancreatic, sarcoma and thyroid cancers.

Also known as: NTRK fusion positive neoplasm, NTRK fusion positive solid tumor, NTRK fusion positive solid tumour, neurotrophic tyrosine receptor kinase fusion positive cancer, neurotrophic tyrosine receptor kinase fusion positive neoplasm, neurotrophic tyrosine receptor kinase fusion positive solid tumor, neurotrophic tyrosine receptor kinase fusion positive solid tumour

1450 clinical trials for this condition and its sub-types, 19 tagged with NTRK fusion positive cancer itself.